Alpha 2.0
Login Register
» Authors » Richard A de Vries

Richard A de Vries

Explore the profile of Richard A de Vries including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 411
Followers 0
Related Specialties
Gastroenterology
Pharmacology
Microbiology
Top 10 Co-Authors
Annemarie C de Vries
Herman van Dekken
Jelle Haringsma
Frank Ter Borg
Ernst J Kuipers
Bettina E Hansen
Elke Verhey
Ewout W Steyerberg
Joost P H Drenth
Karel J van Erpecum
Published In
Gastrointest Endosc
Helicobacter
Pathophysiol Haemost Thromb
J Hepatol
Am J Gastroenterol
Affiliations
Soon will be listed here.
Recent Articles
1.
Percutaneous Irreversible Electroporation of a Large Centrally Located Hepatocellular Adenoma in a Woman with a Pregnancy Wish
Scheffer H, Melenhorst M, van Tilborg A, Nielsen K, van Nieuwkerk K, de Vries R, et al.
Cardiovasc Intervent Radiol . 2014 Dec; 38(4):1031-5. PMID: 25537309
Irreversible electroporation (IRE) is a novel image-guided ablation technique that is rapidly gaining popularity in the treatment of malignant liver tumors located near large vessels or bile ducts. We describe...
2.
Biopsy strategies for endoscopic surveillance of pre-malignant gastric lesions
de Vries A, Haringsma J, de Vries R, Borg F, van Grieken N, Meijer G, et al.
Helicobacter . 2010 Jul; 15(4):259-64. PMID: 20633186
Background: Endoscopic surveillance of pre-malignant gastric lesions may add to gastric cancer prevention. However, the appropriate biopsy regimen for optimal detection of the most advanced lesions remains to be determined....
3.
The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis
Capelle L, de Vries A, Haringsma J, Borg F, de Vries R, Bruno M, et al.
Gastrointest Endosc . 2010 Apr; 71(7):1150-8. PMID: 20381801
Background: The OLGA (operative link on gastritis assessment) staging system is based on severity of atrophic gastritis (AG). AG remains a difficult histopathologic diagnosis with low interobserver agreement, whereas intestinal...
4.
No beneficial effects of amantadine in treatment of chronic hepatitis C patients
van Soest H, Van der Schaar P, Koek G, de Vries R, van Ooteghem N, van Hoek B, et al.
Dig Liver Dis . 2009 Dec; 42(7):496-502. PMID: 20018575
Background: Benefit of adding amantadine to antiviral therapy for hepatitis C is controversial. Aims: We aimed to examine whether such policy enhances sustained viral response in treatment-naïve patients. Methods: 297...
5.
Serum levels of leptin as marker for patients at high risk of gastric cancer
Capelle L, de Vries A, Haringsma J, Steyerberg E, Looman C, Nagtzaam N, et al.
Helicobacter . 2009 Nov; 14(6):596-604. PMID: 19889078
Background: Serological screening for gastric cancer (GC) may reduce mortality. However, optimal serum markers for advanced gastric precursor lesions are lacking. Aim: To evaluate in a case-control study whether serum...
6.
Influence of alpha-1 antitrypsin heterozygosity on treatment efficacy of HCV combination therapy
Kok K, van Soest H, van Herwaarden A, van Oijen M, Boland G, Halangk J, et al.
Eur J Gastroenterol Hepatol . 2009 Oct; 22(7):808-12. PMID: 19794310
Background: The role of heterozygosity for alpha-1 antitrypsin (A1AT) alleles in patients with chronic hepatitis C virus (HCV) is unclear. There is limited evidence to suggest that there is an...
7.
Early HBeAg loss during peginterferon alpha-2b therapy predicts HBsAg loss: results of a long-term follow-up study in chronic hepatitis B patients
Buster E, Flink H, Simsek H, Heathcote E, Sharmila S, Kitis G, et al.
Am J Gastroenterol . 2009 Jul; 104(10):2449-57. PMID: 19584831
Objectives: Treatment with pegylated interferon (PEG-IFN) alpha-2b results in hepatitis B e antigen (HBeAg) loss in 36% of patients at 6 months post treatment. The aim of this study was...
8.
The use of clinical, histologic, and serologic parameters to predict the intragastric extent of intestinal metaplasia: a recommendation for routine practice
de Vries A, Haringsma J, de Vries R, Borg F, Nagtzaam N, Steyerberg E, et al.
Gastrointest Endosc . 2009 Mar; 70(1):18-25. PMID: 19249770
Background: Surveillance of intestinal metaplasia (IM) of the gastric mucosa should be limited to patients at high risk of gastric cancer. Patients with extensive IM are at increased cancer risk;...
9.
Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid
Kuiper E, Hansen B, de Vries R, den Ouden-Muller J, van Ditzhuijsen T, Haagsma E, et al.
Gastroenterology . 2009 Feb; 136(4):1281-7. PMID: 19208346
Background & Aims: Ursodeoxycholic acid (UDCA) improves laboratory liver test results in patients with primary biliary cirrhosis (PBC). Few studies have assessed the prognostic significance of biochemical data collected following...
10.
Severity of iron overload of proband determines serum ferritin levels in families with HFE-related hemochromatosis: the HEmochromatosis FAmily Study
Jacobs E, Hendriks J, van Deursen C, Kreeftenberg H, de Vries R, Marx J, et al.
J Hepatol . 2008 Nov; 50(1):174-83. PMID: 19008010
Background/aims: In families of patients with clinically detected hereditary hemochromatosis (HH) early screening has been suggested to prevent morbidity and mortality. Here, we aim to identify determinants for iron overload...